BRITTANY SILVERMAN: Open Payments
NPI 1720545239 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,214 in 175 payments from 23 companies in 2025. Trend: 2023 $3,688 · 2024 $3,250 · 2025 $3,214
Food & beverage: $3,053Education: $161
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $418 |
| ABBVIE INC. | 30 | $382 |
| GENZYME CORPORATION | 14 | $378 |
| Janssen Biotech, Inc. | 20 | $351 |
| Organon LLC | 21 | $316 |
| UCB, Inc. | 19 | $285 |
| Regeneron Healthcare Solutions, Inc. | 5 | $143 |
| PFIZER INC. | 6 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| Botanix SB Inc | 4 | $92 |
Products named: DUPIXENT, TREMFYA, VTAMA, Bimzelx, ILUMYA, SKYRIZI, RINVOQ, CIBINQO.
Industry payments across AZ — which companies pay providers there.
